Project Grant R01DK149346
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $872,273 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify modifiable process delays in deceased donor kidney allocation through process mining analysis. The project applies process mining methodology to discover actual kidney placement workflows from data logs at multiple organ procurement organizations (OPOs). The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $847,495 on February 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to build expert consensus on stratified kidney allocation design, estimate the policy impact of stratified allocation systems to assist policymakers, and investigate patient, care partner, and provider attitudes and perceptions regarding shared decision-making...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $847,498 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and validate strategies for integrating deceased-donor-initiated kidney paired donation (DD-KPD) chains into the U.S. kidney allocation system. The project addresses the kidney shortage and stagnation in living donation by redirecting a small percentage of deceased...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $1.65 million on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate and design a new kidney allocation policy permitting ABO-compatible transplants. The research addresses a persistent gap in the current U.S. kidney allocation system: high-sensitized patients with blood types B and O remain underserved despite the 2014 policy...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $800,434 on August 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a conditional cash transfer and basic needs resolution intervention for low-income adults with Type 2 Diabetes. The award funds research addressing the disproportionate burden of Type 2 Diabetes among individuals living below 133...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $2,745,108 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK143260). The recipient will develop microfluidic devices that replicate the dimensions and branched structures of human kidney vasculature to investigate systemic amyloidosis. The devices will subject...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $2,557,884 on September 10, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a detailed analysis of long-term health outcomes in living kidney donors using real-world electronic health records. The recipient will analyze the COSMOS dataset, which encompasses electronic health records from over 245 million individuals...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University (doing business as New York University School of Medicine) $1.674 million on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop an empirically-based, optimal prehabilitation program for kidney transplant candidates on hemodialysis. The research addresses a significant clinical need: of more than 140,000 people waiting for kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $877,742 on September 2, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the effect of a state-wide centralized patient coaching program about live donor kidney transplantation. The award funds the Live Donor Champion (LDC) program, which educates end-stage kidney disease patients, their caregivers, and social...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $1,527,305 to The Research Foundation For The State University Of New York (operating as Stony Brook University) on August 21, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on C-terminal binding protein 2 (CTBP2) as a therapeutic target in acute kidney injury. The research identifies CTBP2, a redox-sensitive, NAD/NADH-dependent transcriptional...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation for the State University of New York $327,450 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on reducing geographic disparity in access to deceased donor kidney transplantation. The recipient will employ advanced statistical methods, artificial intelligence, and operations research to understand complex dynamics within the organ allocation system and inform policy changes that reduce geographic disparity while mitigating unintended systemic inefficiencies. The research addresses three specific aims: determining the causal effect of allocation out-of-sequence on geographic disparity; characterizing the interplay between geographic disparity and transplant center organ acceptance behavior over time; and identifying optimal kidney allocation boundaries that jointly minimize geographic disparity and organ transplantation system inefficiencies. The work responds to substantial geographic variation in deceased donor kidney transplant wait times, which currently vary up to tenfold across the United States and contribute to approximately half of waitlist candidates becoming too ill for transplant. A 2021 organ allocation policy designed to reduce this disparity through wider organ sharing has created unintended consequences including increased wait time uncertainty and higher organ non-use rates. Performance occurs in Buffalo, New York, with a period of performance from August 20, 2026, through May 31, 2031. The Research Foundation for the State University of New York serves as fiscal agent for the State University of New York system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $327.5k | 8/20/26 |